These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28625828)

  • 1. Precision monitoring of immunotherapies in solid organ and hematopoietic stem cell transplantation.
    DiLoreto R; Khush K; De Vlaminck I
    Adv Drug Deliv Rev; 2017 May; 114():272-284. PubMed ID: 28625828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome in solid organ transplantation.
    Baghai Arassi M; Zeller G; Karcher N; Zimmermann M; Toenshoff B
    Pediatr Transplant; 2020 Nov; 24(7):e13866. PubMed ID: 32997434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
    Brunet M; van Gelder T; Åsberg A; Haufroid V; Hesselink DA; Langman L; Lemaitre F; Marquet P; Seger C; Shipkova M; Vinks A; Wallemacq P; Wieland E; Woillard JB; Barten MJ; Budde K; Colom H; Dieterlen MT; Elens L; Johnson-Davis KL; Kunicki PK; MacPhee I; Masuda S; Mathew BS; Millán O; Mizuno T; Moes DAR; Monchaud C; Noceti O; Pawinski T; Picard N; van Schaik R; Sommerer C; Vethe NT; de Winter B; Christians U; Bergan S
    Ther Drug Monit; 2019 Jun; 41(3):261-307. PubMed ID: 31045868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.
    Chong PP; Avery RK
    Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic Risk Assessment and Approach to Immunosuppression Regimen in Kidney Transplantation.
    Choi J; Chandraker A
    Clin Lab Med; 2019 Dec; 39(4):643-656. PubMed ID: 31668275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaching the promise of operational tolerance in clinical transplantation.
    Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
    Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.
    Strober S
    Blood; 2016 Mar; 127(12):1539-43. PubMed ID: 26796362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive Therapy in Transplantation.
    Allison TL
    Nurs Clin North Am; 2016 Mar; 51(1):107-20. PubMed ID: 26897428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in precision medicine for individualized immunosuppression.
    Fu S; Zarrinpar A
    Curr Opin Organ Transplant; 2020 Aug; 25(4):420-425. PubMed ID: 32520785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
    Smedman TM; Line PD; Guren TK; Dueland S
    Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
    [No Abstract]   [Full Text] [Related]  

  • 12. The gut microbiota in transplant patients.
    Chong PP; Koh AY
    Blood Rev; 2020 Jan; 39():100614. PubMed ID: 31492463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance induction by removal of alloreactive T cells: in-vivo and pruning strategies.
    Watson D; Hu M; Zhang GY; Wang YM; Alexander SI
    Curr Opin Organ Transplant; 2009 Aug; 14(4):357-63. PubMed ID: 19610169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance in Solid-Organ Transplant.
    Fine RN
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):1-5. PubMed ID: 27805501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic Monitoring to Personalize Immunosuppression After Liver Transplant.
    Zhu A; Leto A; Shaked A; Keating B
    Gastroenterol Clin North Am; 2018 Jun; 47(2):281-296. PubMed ID: 29735024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Erpicum P; Weekers L; Detry O; Bonvoisin C; Delbouille MH; Grégoire C; Baudoux E; Briquet A; Lechanteur C; Maggipinto G; Somja J; Pottel H; Baron F; Jouret F; Beguin Y
    Kidney Int; 2019 Mar; 95(3):693-707. PubMed ID: 30528263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel immune function biomarker identifies patients at risk of clinical events early following liver transplantation.
    Sood S; Haifer C; Yu L; Pavlovic J; Churilov L; Gow PJ; Jones RM; Angus PW; Visvanathan K; Testro AG
    Liver Transpl; 2017 Apr; 23(4):487-497. PubMed ID: 28133934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tolerance of vascularized composite allografts.
    Leonard DA; Cetrulo CL; McGrouther DA; Sachs DH
    Transplantation; 2013 Feb; 95(3):403-9. PubMed ID: 23114532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression.
    Bush WW
    AACN Clin Issues; 1999 May; 10(2):253-69; quiz 304-6. PubMed ID: 10578712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry and solid organ transplantation: a perfect match.
    Maguire O; Tario JD; Shanahan TC; Wallace PK; Minderman H
    Immunol Invest; 2014; 43(8):756-74. PubMed ID: 25296232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.